Endo DNA

What Endo DNA does

EndoDNA + BIOS is a precision health intelligence platform that integrates genomics, biomarkers, lifestyle inputs, wearable data, and machine learning into a clinical decision-support system sold to licensed healthcare practitioners. The platform combines the EndoDNA Genomic Analysis Engine — which performs clinical-grade sequencing of millions of SNPs across 20,000+ genes via Illumina next-generation sequencing with 98.6% genotyping accuracy, processed through CAP/CLIA-accredited laboratories using FDA-validated MAWI saliva collection devices — with BIOS BRAIN, a proprietary cognitive architecture (Biomedical Reasoning & Adaptive Inference Network) featuring four memory networks (World, Experience, Opinion, Observation), temporal reasoning, belief management, and continuous learning from practitioner feedback and patient outcomes. A single DNA sample generates pathway-level reports across 15+ wellness categories, including specialized panels for Female Hormone Health (130+ variants, 19 categories), Male Hormone Health (170+ variants, 21 categories), NeuroDNA (300+ variants, 23 categories), NutriDNA, SkinDNA, Regenerative Health, and an Endocannabinoid (ECS) DNA panel.

The company's business model is B2B enterprise sales to clinical practices, with quote-based subscription pricing, one-time testing fees, recurring revenue from report upgrades, and optional supplement protocol sales. The go-to-market targets functional and integrative medicine practices, hormone optimization clinics (HRT/TRT), longevity and regenerative medicine providers, medspas and aesthetic practices, and direct-pay or telehealth practices. A white-label program allows clinics to brand the platform under their own identity. The company holds 5 US Patents on its ML engine and operates from a California headquarters with a small team (~12-15 named individuals plus advisory board). No revenue, funding, or customer-count figures are publicly disclosed, and the company appears to be at an early commercial stage with limited named customer references.

Name

Endo DNA

Legal name

EndoDNA+BIOS

Website

https://endodna.com

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

11–50 employees

Short description

EndoDNA + BIOS is a precision health intelligence platform that combines clinical-grade genomic sequencing with a proprietary AI cognitive architecture (BIOS BRAIN) to translate DNA, biomarker, and wearable data into actionable clinical insights for licensed healthcare practitioners across functional, hormone, regenerative, longevity, and aesthetic medicine practices.

Ownership category

akta.pro rank

Product category

Clinical Genomics Software

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Clinical genomics software
• Precision health platform
• DNA analysis reports
• Functional medicine genomics
• Pathway-based genetic testing

Headquarters

HQ city

Burbank

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. DNA Genomic Testing: Revenue from genomic testing services. One test generates multiple insights with high patient perceived value. Direct revenue per test from CAP/CLIA-accredited laboratory processing.
2. Report Upgrades & Panel Generation: Once patient DNA is captured, additional reports can be generated across expanded wellness categories without additional sample collection. New insights delivered over time create compounding revenue per patient.
3. Supplements & Treatment Protocols: Genomic insight leads to personalized supplement protocols and targeted interventions. Supplement reorder integration built into treatment plans enables recurring revenue through eCommerce.
4. Platform Subscription Access: Subscription-based access to BIOS platform, clinical decision support, and practice management tools. Revenue-aligned models include panel resale and upgrade options for participating clinics.
5. Test Markups & Reorders: Clinics can generate income from test markups, supplements, and reorders, stated as potential $10k/month revenue opportunity for practices.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

EndoDNA + BIOS is a precision health intelligence platform that integrates genomics, biomarkers, lifestyle data, wearable inputs, and machine learning into a unified clinical decision-support system for licensed healthcare practitioners. It analyzes millions of SNPs across 20,000+ genes from a single patient DNA sample (via Illumina NGS, CAP/CLIA labs) and translates the results into structured, actionable insights through the proprietary BIOS BRAIN cognitive AI architecture, including specialty reports on hormone health, neuro, nutrition, skin, and endocannabinoid response.

Product overview

EndoDNA + BIOS is a unified precision health intelligence platform consisting of two core components: the EndoDNA genomic analysis engine (powered by clinical-grade sequencing analyzing millions of SNPs across 20,000+ genes) and the BIOS BRAIN clinical support layer (an AI-powered cognitive architecture). The platform offers multiple specialized DNA report panels including Female Hormone Health DNA Report, Male Hormone Health DNA Report, NeuroDNA Report, NutriDNA Report, SkinDNA Report, Regenerative Health, and ECS/Endocannabinoid DNA Panel. Reports can be generated from a single DNA sample with unlimited future reports as new panels are developed. A white-label program enables practices to brand the platform under their own identity.

Differentiator

Problem solved

Functional benefit

Brands

• BIOS: Clinical intelligence layer that translates genomic data into structured, actionable insights. Also known as BIOS BRAIN (Biomedical Reasoning & Adaptive Inference Network) - a cognitive architecture designed to mirror how clinicians reason, featuring AI genome interrogation, four memory networks, temporal reasoning, belief management, and continuous learning capabilities.
• NeuroDNA
• NutriDNA
• SkinDNA
• Regenerative Health
• ECS/Endocannabinoid DNA Panels

Products and services

• EndoDNA + BIOS Platform Core precision health intelligence platform combining the EndoDNA genomic analysis engine with the BIOS BRAIN AI cognitive architecture, providing licensed healthcare practitioners with structured clinical decision support. Includes pathway-level genomic analysis, natural-language chat interface, wearable and lab data integration, EMR-compatible export, and white-label practice branding.
• Female Hormone Health DNA Report Pathway-driven genomic blueprint analyzing 130+ genetic variants across 19 clinical categories for female hormone metabolism, receptor sensitivity, menopause biotyping, and regenerative care. For clinicians serving female patients requiring hormone personalization.
• Male Hormone Health DNA Report Pathway-driven genomic analysis evaluating 170+ genetic variants across 21 clinical categories for male hormone optimization, testosterone metabolism, performance, and cardiometabolic function. For practitioners offering hormone replacement and TRT protocols.
• NeuroDNA Report Neurogenomic blueprint analyzing 300+ genetic variants across 23 neurological categories including neurotransmitter function, inflammation, cognition, stress response, and sleep regulation. For clinicians addressing cognitive, mood, and sleep concerns.
• NutriDNA Report Genomic nutrition intelligence report revealing how patients process vitamins, minerals, and key metabolic pathways across vitamin metabolism, mineral absorption, and detoxification. For clinicians building targeted nutritional strategies.
• SkinDNA Report Dermatogenomic intelligence report analyzing genetic variants across skin pathways including collagen production, UV response, hydration, pigmentation, inflammation, and antioxidant defense. For medspas and aesthetic medicine practitioners.
• Regenerative Health Genomic Test Patented genomic test powering hormone personalization and risk stratification for female and male hormone health, menopause biotyping, and longevity optimization. Anchors regenerative medicine protocol development.
• ECS/Endocannabinoid DNA Panel Validated endocannabinoid system genomic test covering FAAH, CNR1, CNR2, COMT, and full CYP450 cannabinoid metabolizer pathways with cross-referencing to drug metabolism for cannabis-based therapies. The company's originally differentiating cannabis-genomics product.
• White-Label & Practice Branding Program White-label program enabling practices to launch their own branded DNA testing services with custom saliva kits, co-branded reports, a test management console, marketing resources, and CME education.

Quantifiable outcome

• Revenue generation of $10k/month for clinics from test markups, supplements, and reorders
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability10 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• IlluminacoreTechnology or IntegrationUses Illumina next-generation sequencing (NGS) technology for genomic analysis with 98.6% genotyping accuracy. Primary sequencing technology provider for EndoDNA platform.
• 23andMecoreTechnology or IntegrationPlatform accepts raw data uploads from 23andMe for immediate BIOS analysis. Interoperable with consumer genetic data sources.
• AncestryDNAcoreTechnology or IntegrationPlatform accepts raw data uploads from AncestryDNA for immediate BIOS analysis. Interoperable with consumer genetic data sources.
• MAWI (FDA-Validated Saliva Collection)coreTechnology or IntegrationUses FDA-validated MAWI saliva collection devices for reliable, painless at-home sample collection. Ensures sample quality and chain-of-custody compliance.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Viome: Viome combines gut microbiome, transcriptomic, and blood testing to drive personalized nutrition and supplement recommendations. It is comparable to EndoDNA on multi-omics precision health intelligence and recurring supplement revenue, though it focuses on microbiome/transcriptomics rather than SNPs.
• MTHFR Support: MTHFR Support offers genetic testing and clinical reports focused on methylation, MTHFR variants, and related nutrigenomic pathways for practitioners and patients. It overlaps EndoDNA's NutriDNA and pathway-level interpretation focus and shares the functional/integrative medicine customer base.

Direct peers

• SelfDecode: SelfDecode offers practitioner- and consumer-facing DNA-based health reports covering wellness, nutrition, hormones, and cognitive function. It is comparable to EndoDNA in business model (DNA report subscriptions, pathway-level analysis) and target market (functional/integrative medicine and direct-pay consumers).
• InsideTracker: InsideTracker integrates blood biomarkers, DNA, and wearable data to deliver personalized longevity and wellness insights, with both consumer and practitioner offerings. It is comparable to EndoDNA on multi-modal data fusion and pathway-level interpretation for hormone, longevity, and performance use cases.
• Nutrition Genome: Nutrition Genome provides DNA-based nutrition and wellness reports for both consumers and practitioners, focused on nutrient metabolism, detox pathways, and supplement personalization. It directly overlaps EndoDNA's NutriDNA report category and clinician-channel DNA report model.
• Function Health: Function Health offers a membership-based precision health testing platform combining 100+ lab biomarkers with practitioner follow-up. It is comparable to EndoDNA as a precision health intelligence layer for direct-pay, longevity-focused consumers and practitioners.
• Genomind: Genomind provides pharmacogenomic and mental-health-focused genetic testing for clinicians, with professional PGx reports and decision support. It overlaps EndoDNA's NeuroDNA and pharmacogenomics capabilities and shares the B2B clinician sales motion and CLIA-lab processing model.

Broad incumbents

• 23andMe: 23andMe is the leading consumer DNA testing platform, whose raw data EndoDNA explicitly ingests via its BIOS pipeline. It is comparable as the upstream data source for clinical interpretation and as the dominant consumer genomic brand EndoDNA positions against.
• Color Health: Color provides clinical-grade genetic testing across hereditary cancer, pharmacogenomics, and hereditary conditions, with employer- and clinician-facing distribution. It is comparable to EndoDNA as a clinical genomics platform with EHR integration, though Color is more diagnostic and population-scale while EndoDNA focuses on functional medicine decision support.
• Thorne: Thorne is a large, established personalized supplement and wellness brand with practitioner distribution and increasingly genomics-informed product lines. It is comparable to EndoDNA on the supplement-and-protocol monetization layer and on shared practitioner channel, though Thorne's core is supplements, not interpretation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/endocannah
• Facebookfacebook.com/EndoCannahealth
• LinkedInlinkedin.com/company/endocanna-health

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Endo DNA